Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - Cardiovascular Systems Inc | ex322-63015.htm |
| 10-K - 10-K - Cardiovascular Systems Inc | csii10-kx63015.htm |
| EX-31.2 - EXHIBIT 31.2 - Cardiovascular Systems Inc | ex312-63015.htm |
| EX-32.1 - EXHIBIT 32.1 - Cardiovascular Systems Inc | ex321-63015.htm |
| EX-31.1 - EXHIBIT 31.1 - Cardiovascular Systems Inc | ex311-63015.htm |
| EX-10.10 - EXHIBIT 10.10 - Cardiovascular Systems Inc | ex1010-fy16basesalaries.htm |
| EX-10.12 - EXHIBIT 10.12 - Cardiovascular Systems Inc | ex1012-fy16directorcomp.htm |
| EX-10.11 - EXHIBIT 10.11 - Cardiovascular Systems Inc | ex1011-fy16execincentivepl.htm |
| EX-10.59 - EXHIBIT 10.59 - Cardiovascular Systems Inc | ex1059-2014equityincentive.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-135954, 333-158755, 333-158987, 333-160609, 333-160610, 333-168682, 333-168684, 333-175702, 333-175703, 333-182668, 333-182669, 333-189856, 333-189858, 333-197348, 333-197350, 333-200214, and 333-205578) of Cardiovascular Systems, Inc. of our report dated August 27, 2015 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
Minneapolis, Minnesota
August 27, 2015